{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:20:53Z","timestamp":1793834453464,"version":"4.6.1"},"reference-count":199,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1053\/j.gastro.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:16:09Z","timestamp":1771330569000},"page":"1261-1282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Bowel Disorders"],"prefix":"10.1053","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-4684","authenticated-orcid":false,"given":"Maura","family":"Corsetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks D.","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Simr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Schmulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.02.003_bib1","article-title":"Global prevalence, characterization and impact of functional bowel disorders","author":"Tornkvist","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cgh.2019.08.016","article-title":"Effects of irritable bowel syndrome on daily activities vary among subtypes based on results from the IBS in America Survey","volume":"17","author":"Ballou","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.cgh.2023.01.017","article-title":"The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs","volume":"21","author":"Bosman","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12876-019-0985-1","article-title":"Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries","volume":"19","author":"Tack","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/apt.16939","article-title":"Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14581","article-title":"Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study","volume":"35","author":"Fukudo","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13030-023-00286-1","article-title":"Cognition of abdominal pain and abdominal discomfort in Chinese patients with irritable bowel syndrome with diarrhea","volume":"17","author":"Lu","year":"2023","journal-title":"Biopsychosoc Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"Aziz","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2004.02.020","article-title":"Irritable bowel syndrome and surgery: a multivariable analysis","volume":"126","author":"Longstreth","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gutjnl-2020-322519","article-title":"Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"70","author":"Black","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14004","article-title":"A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: a five-year follow-up of a randomized controlled trial","volume":"33","author":"Engsbro","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.3399\/bjgp18X698321","article-title":"Patients' perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care","volume":"68","author":"Sibelli","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1053\/j.gastro.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajg.2013.56","article-title":"2012 David Sun lecture: helping your patient by helping yourself\u2014how to improve the patient-physician relationship by optimizing communication skills","volume":"108","author":"Drossman","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/13548506.2017.1417613","article-title":"Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance","volume":"23","author":"Hulme","year":"2018","journal-title":"Psychol Health Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/bmj.325.7366.682","article-title":"Spontaneous talking time at start of consultation in outpatient clinic: cohort study","volume":"325","author":"Langewitz","year":"2002","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5056\/jnm25007","article-title":"2025 Seoul Consensus on clinical practice guidelines for irritable bowel syndrome","volume":"31","author":"Choi","year":"2025","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA Clinical Practice Guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib23","first-page":"168","article-title":"The Mexican consensus on chronic constipation","volume":"83","author":"Remes-Troche","year":"2018","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1053\/j.gastro.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5056\/jnm19041","article-title":"Second Asian consensus on irritable bowel syndrome","volume":"25","author":"Gwee","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ueg2.12259","article-title":"Functional bowel disorders with diarrhoea: clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility","volume":"10","author":"Savarino","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.51821\/85.2.10100","article-title":"Belgian consensus on irritable bowel syndrome","volume":"85","author":"Kindt","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1053\/j.gastro.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.dld.2022.11.015","volume":"55","author":"Barbara","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00535-014-1017-0","article-title":"Evidence-based clinical practice guidelines for irritable bowel syndrome","volume":"50","author":"Fukudo","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib30","first-page":"259","article-title":"Guidelines on the management of irritable bowel syndrome: in memory of Professor Witold Bartnik","volume":"13","author":"Pietrzak","year":"2018","journal-title":"Prz Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12664-022-01333-5","article-title":"Indian consensus statements on irritable bowel syndrome in adults: a guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology","volume":"42","author":"Ghoshal","year":"2023","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5056\/jnm17145","article-title":"Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 Revised Edition","volume":"24","author":"Song","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13762","article-title":"European Society of Neurogastroenterology and Motility guidelines on functional constipation in adults","volume":"32","author":"Serra","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/apt.17754","article-title":"Systematic review with meta-analysis: diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults","volume":"58","author":"Dajti","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","article-title":"American College of Gastroenterology guidelines update: diagnosis and management of celiac disease","volume":"118","author":"Rubio-Tapia","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1111\/jgh.70074","article-title":"Prevalence of serologically defined celiac disease in patients with irritable bowel syndrome in Asia: a multicountry hospital-based study","volume":"40","author":"Ahmed","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.14309\/ajg.0000000000003586","article-title":"Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: a systematic review and meta-analysis","volume":"120","author":"Shiha","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.gtc.2006.03.006","article-title":"An updated review on Cryptosporidium and Giardia","volume":"35","author":"Huang","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cgh.2009.09.032","article-title":"Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency","volume":"8","author":"Leeds","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jgh.13791","article-title":"Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain","volume":"32","author":"Talley","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2468-1253(17)30154-1","article-title":"Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis","volume":"2","author":"Storhaug","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3390\/nu14091923","article-title":"Carbohydrate maldigestion and intolerance","volume":"14","author":"Fernandez-Banares","year":"2022","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.14309\/01.ajg.0000858784.76832.20","article-title":"Prevalence of disaccharidase deficiencies in adults with irritable bowel syndrome and functional diarrhea: interim analysis from a multicenter, prospective US trial","volume":"117","author":"Chey","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ueg2.12133","volume":"10","author":"Hammer","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12664-022-01292-x","article-title":"Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian Neurogastroenterology and Motility Association","volume":"41","author":"Ghoshal","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14817","article-title":"Critical appraisal of the SIBO hypothesis and breath testing: a clinical practice update endorsed by the European Society of Neurogastroenterology and Motility (ESNM) and the American Neurogastroenterology and Motility Society (ANMS)","volume":"36","author":"Kashyap","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ajg.2010.55","article-title":"The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial","volume":"105","author":"Chey","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365521.2015.1007079","article-title":"Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey","volume":"50","author":"Patel","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gut.2008.159723","article-title":"Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis","volume":"57","author":"Ford","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/apt.18003","article-title":"Diagnostic yield from symptomatic lower gastrointestinal endoscopy in the UK: A British Society of Gastroenterology analysis using data from the National Endoscopy Database","volume":"59","author":"Beaton","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ajg.2013.52","article-title":"Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies","volume":"108","author":"Power","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cgh.2016.06.030","article-title":"Uncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disorders","volume":"14","author":"Linedale","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2018.07.011","article-title":"Rome Foundation working team report on post-infection irritable bowel syndrome","volume":"156","author":"Barbara","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome\u2014a systematic review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib59","article-title":"A systematic review and meta-analysis of diet and nutrient intake in adults with irritable bowel syndrome","author":"Veraza","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00384-023-04333-9","article-title":"The role of psychological factors in functional gastrointestinal disorders: a systematic review and meta-analysis","volume":"38","author":"Yan","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2011.01.032","article-title":"The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome","volume":"140","author":"Chang","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2004.04.029","article-title":"Unnecessary abdominal and back surgery in irritable bowel syndrome: time to stem the flood now?","volume":"126","author":"Talley","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","article-title":"Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis","volume":"152","author":"Klem","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14187","article-title":"Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: a controlled cohort study","volume":"34","author":"Noviello","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib65","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0016-5085(94)90228-3","article-title":"Gastrointestinal tract symptoms and self-reported abuse: a population-based study","volume":"107","author":"Talley","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.gastro.2019.04.019","article-title":"Cumulative effects of psychologic distress, visceral hypersensitivity, and abnormal transit on patient-reported outcomes in irritable bowel syndrome","volume":"157","author":"Simren","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2016.09.062","article-title":"Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome","volume":"152","author":"Major","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14515","article-title":"Factors influencing rectal hypersensitivity in irritable bowel syndrome: a systematic review and meta-analysis","volume":"35","author":"Roberts","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/eujp.2000.0167","article-title":"Gender differences in regional brain response to visceral pressure in IBS patients","volume":"4","author":"Berman","year":"2000","journal-title":"Eur J Pain"},{"key":"10.1053\/j.gastro.2026.02.003_bib70","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2982.2011.01866.x","article-title":"Heart rate variability in the irritable bowel syndrome: a review of the literature","volume":"24","author":"Mazurak","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.dld.2009.07.007","article-title":"Infection, inflammation, and the irritable bowel syndrome","volume":"41","author":"Spiller","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2026.02.003_bib72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.gtc.2021.02.007","article-title":"Post-infection irritable bowel syndrome","volume":"50","author":"Berumen","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1053\/j.gastro.2020.02.022","article-title":"Prostaglandin E(2), produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice","volume":"158","author":"Grabauskas","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local immune response to food antigens drives meal-induced abdominal pain","volume":"590","author":"Aguilera-Lizarraga","year":"2021","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib76","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study","volume":"42","author":"Bearcroft","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib79","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-2036.2004.02284.x","article-title":"Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario","volume":"20","author":"Marshall","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib80","doi-asserted-by":"crossref","first-page":"G919","DOI":"10.1152\/ajpgi.00168.2011","article-title":"Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls","volume":"301","author":"Rao","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.gastro.2026.02.003_bib81","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1572-0241.2006.00672.x","article-title":"Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes","volume":"101","author":"Dunlop","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000333083","article-title":"Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis","volume":"85","author":"Gecse","year":"2012","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2026.02.003_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report","volume":"62","author":"Simren","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib84","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","article-title":"Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome","volume":"182","author":"Mars","year":"2020","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2026.02.003_bib85","article-title":"Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: course ahead in research and clinical practice","volume":"62\u201363","author":"Colomier","year":"2023","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib86","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"AGA clinical practice update on small intestinal bacterial overgrowth: expert review","volume":"159","author":"Quigley","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2982.2009.01447.x","article-title":"Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome","volume":"22","author":"Serra","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gutjnl-2012-303013","article-title":"Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet","volume":"63","author":"Manichanh","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib89","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2014.07.046","article-title":"Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome","volume":"147","author":"Fritscher-Ravens","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2019.03.046","article-title":"Many patients with irritable bowel syndrome have atypical food allergies not associated with immunoglobulin E","volume":"157","author":"Fritscher-Ravens","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib91","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/gut.2003.037697","article-title":"Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial","volume":"53","author":"Atkinson","year":"2004","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib92","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1053\/j.gastro.2025.01.223","article-title":"A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: a randomized, sham-controlled trial","volume":"168","author":"Singh","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib93","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000541","article-title":"Associations of fecal short chain fatty acids with colonic transit, fecal bile acid, and food intake in irritable bowel syndrome","volume":"14","author":"Waseem","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib94","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MCG.0000000000001521","article-title":"Associations of habitual dietary intake with fecal short-chain fatty acids and bowel functions in irritable bowel syndrome","volume":"56","author":"Calderon","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib95","article-title":"Physical activity for treatment of irritable bowel syndrome","volume":"6","author":"Nunan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2026.02.003_bib96","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2014.195","article-title":"The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis","volume":"109","author":"Moayyedi","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib97","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S2468-1253(25)00054-8","article-title":"Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"10","author":"Cuffe","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib98","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib99","first-page":"77","article-title":"Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociacion Mexicana de Gastroenterologia, 2024","volume":"90","author":"Remes-Troche","year":"2025","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1053\/j.gastro.2026.02.003_bib100","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ajg.2013.197","article-title":"Randomized clinical trial: macrogol\/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome","volume":"108","author":"Chapman","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib101","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2014results of two randomized, placebo-controlled studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib102","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib103","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib104","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib105","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.cgh.2020.02.027","article-title":"Effects of colesevelam on bowel symptoms, biomarkers, and colonic mucosal gene expression in patients with bile acid diarrhea in a randomized trial","volume":"18","author":"Vijayvargiya","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gutjnl-2013-305965","article-title":"Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS","volume":"64","author":"Bajor","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365528709091003","article-title":"Loperamide in treatment of irritable bowel syndrome\u2014a double-blind placebo controlled study","volume":"130","author":"Lavo","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365528709091004","article-title":"Loperamide treatment of the irritable bowel syndrome","volume":"130","author":"Hovdenak","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.02.003_bib111","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/apt.17179","article-title":"Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome","volume":"56","author":"Ingrosso","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib112","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.02.003_bib113","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/apt.17426","article-title":"Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: the TRITON trial","volume":"57","author":"Gunn","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib114","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2023.07.018","article-title":"Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis","volume":"165","author":"Goodoory","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib116","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib117","article-title":"Effectiveness of rifaximin on the outcomes of irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"10.1053\/j.gastro.2026.02.003_bib118","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3748\/wjg.v29.i20.3185","article-title":"Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis","volume":"29","author":"Halkjaer","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib119","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gutjnl-2023-331634","article-title":"Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial","volume":"73","author":"Decraecker","year":"2024","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cgh.2023.02.014","article-title":"Systematic review and meta-analysis: efficacy of mesalamine in irritable bowel syndrome","volume":"22","author":"Goodoory","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib121","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.cgh.2020.09.035","article-title":"Potential benefit with complementary and alternative medicine in irritable bowel syndrome: a systematic review and meta-analysis","volume":"19","author":"Billings","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib122","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib123","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib124","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(20)30215-6","article-title":"Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial","volume":"5","author":"Basnayake","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ajg.2014.18","article-title":"Chronic constipation, irritable bowel syndrome with constipation and constipation with pain\/discomfort: similarities and differences","volume":"109","author":"Rey","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cgh.2023.08.044","article-title":"Perceptions, definitions, and therapeutic interventions for occasional constipation: a Rome Working Group Consensus Document","volume":"2","author":"Brenner","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib127","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/gutjnl-2015-311240","article-title":"The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review","volume":"66","author":"Sperber","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.02.003_bib128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib129","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1365-2036.2007.03540.x","article-title":"Cumulative incidence of chronic constipation: a population-based study 1988\u20132003","volume":"26","author":"Choung","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1365-2036.2011.04809.x","article-title":"Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)","volume":"34","author":"Zhao","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib131","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/ajg.2013.137","article-title":"Impact of persistent constipation on health-related quality of life and mortality in older community-dwelling women","volume":"108","author":"Koloski","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib132","first-page":"13","article-title":"Quality of life in patients with different constipation subtypes based on the Rome III criteria","volume":"80","author":"Ruiz-Lopez","year":"2015","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1053\/j.gastro.2026.02.003_bib133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/CEG.S239205","article-title":"The humanistic and economic burden of chronic idiopathic constipation in the USA: a systematic literature review","volume":"13","author":"Nag","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib134","doi-asserted-by":"crossref","first-page":"261","DOI":"10.15386\/mpr-1222","article-title":"The economic burden of constipation therapy","volume":"92","author":"Albu","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1053\/j.gastro.2026.02.003_bib135","first-page":"S63","article-title":"Managing costs and care for chronic idiopathic constipation","volume":"25","author":"McCormick","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.gastro.2026.02.003_bib136","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jgh.15295","article-title":"Impact of chronic constipation on health-related quality of life and work productivity in Japan","volume":"36","author":"Tomita","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib137","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14070","article-title":"Chronic constipation in adults: contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment","volume":"33","author":"Corsetti","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib138","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1007\/s10620-021-07288-5","article-title":"Opioid-associated anorectal dysfunction in chronic constipation","volume":"67","author":"Lodhia","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2026.02.003_bib139","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2023.03.214","article-title":"American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation","volume":"164","author":"Chang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14050","article-title":"Chronic constipation in adults: contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation","volume":"33","author":"Scott","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib141","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5056\/jnm23066","article-title":"2022 Seoul consensus on clinical practice guidelines for functional constipation","volume":"29","author":"Cho","year":"2023","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib142","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.3748\/wjg.v18.i36.4994","article-title":"Consensus statement AIGO\/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)","volume":"18","author":"Bove","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib143","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/s0004-2803.202200001-23","article-title":"Diagnosis and management of chronic idiopathic constipation: a narrative review from a Brazilian expert task force","volume":"59","author":"Passos","year":"2022","journal-title":"Arq Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib144","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12664-018-0894-1","article-title":"Indian consensus on chronic constipation in adults: a joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology","volume":"37","author":"Ghoshal","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5056\/jnm15185","article-title":"Guidelines for the diagnosis and treatment of chronic functional constipation in Korea, 2015 revised edition","volume":"22","author":"Shin","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib146","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.gastrohep.2016.02.006","article-title":"Clinical practice guidelines for the management of constipation in adults. Part 1: Definition, aetiology and clinical manifestations","volume":"40","author":"Serra","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib147","first-page":"62","article-title":"Evidence-based clinical guidelines for chronic constipation 2023","volume":"106","author":"Ihara","year":"2025","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2026.02.003_bib148","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.95","article-title":"Chronic constipation","volume":"3","author":"Camilleri","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.gastro.2026.02.003_bib149","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.3748\/wjg.v27.i21.2795","article-title":"Potential risk factors for constipation in the community","volume":"27","author":"Werth","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPG.0b013e3181a0a595","article-title":"Familial clustering of habitual constipation: a prospective study in children from West Virginia","volume":"50","author":"Ostwani","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2026.02.003_bib151","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1572-0241.2003.07591.x","article-title":"Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women","volume":"98","author":"Dukas","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib152","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2013.73","article-title":"Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey","volume":"108","author":"Markland","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib153","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.10.005","article-title":"Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation","volume":"150","author":"Parthasarathy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib154","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ajg.2016.341","article-title":"Pan-colonic pressurizations associated with relaxation of the anal sphincter in health and disease: a new colonic motor pattern identified using high-resolution manometry","volume":"112","author":"Corsetti","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.14309\/ajg.0000000000001039","article-title":"Clinical impact of rectal hyposensitivity: a cross-sectional study of 2,876 patients with refractory functional constipation","volume":"116","author":"Vollebregt","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib156","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0016-5085(85)80128-1","article-title":"Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus","volume":"88","author":"Krishnamurthy","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib157","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00042737-199612000-00014","article-title":"Decreased substance P levels in rectal biopsies from patients with slow transit constipation","volume":"8","author":"Tzavella","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib158","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/BF02063253","article-title":"Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation","volume":"40","author":"Cortesini","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2026.02.003_bib159","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2002.36600","article-title":"Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon","volume":"123","author":"Wedel","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/003655299750025110","article-title":"Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation","volume":"34","author":"El-Salhy","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib161","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0016-5085(00)70409-4","article-title":"Decreased interstitial cell of cajal volume in patients with slow-transit constipation","volume":"118","author":"He","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib162","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0016-5085(89)91500-X","article-title":"Psychological and physiological characteristics of patients with severe idiopathic constipation","volume":"97","author":"Wald","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib163","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ajcn\/nqac184","article-title":"The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"van der Schoot","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2026.02.003_bib164","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1572-0241.2007.01199.x","article-title":"A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation","volume":"102","author":"Dipalma","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cgh.2011.03.026","article-title":"Oral bisacodyl is effective and well-tolerated in patients with chronic constipation","volume":"9","author":"Kamm","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib166","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ajg.2010.41","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation","volume":"105","author":"Mueller-Lissner","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib167","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2016.611","article-title":"A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation","volume":"112","author":"Miner","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib168","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2007.01524.x","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation","volume":"103","author":"Johanson","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib169","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2468-1253(18)30123-7","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial","volume":"3","author":"Nakajima","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib171","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib172","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/j.gastro.2023.02.013","article-title":"Randomized placebo-controlled phase 3 trial of vibrating capsule for chronic constipation","volume":"164","author":"Rao","year":"2023","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2026.02.003_bib173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/codi.13779","article-title":"Surgery for constipation: systematic review and practice recommendations: results I: colonic resection","volume":"19","author":"Knowles","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1053\/j.gastro.2026.02.003_bib174","article-title":"Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2026.02.003_bib175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.gie.2009.11.025","article-title":"The role of endoscopy in the management of patients with diarrhea","volume":"71","author":"ASGE Standards of Practice Committee","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.02.003_bib176","first-page":"535","article-title":"[Chronic diarrhoea: definition, classification and diagnosis]","volume":"39","author":"Fernandez-Banares","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib177","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cgh.2019.08.020","article-title":"Similarities in clinical and psychosocial characteristics of functional diarrhea and irritable bowel syndrome with diarrhea","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib178","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2016.10.014","article-title":"Pathophysiology, evaluation, and management of chronic watery diarrhea","volume":"152","author":"Camilleri","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib179","article-title":"GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome","volume":"1","author":"Bonfiglio","year":"2021","journal-title":"Cell Genom"},{"key":"10.1053\/j.gastro.2026.02.003_bib180","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0016-5085(91)90080-5","article-title":"Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations","volume":"101","author":"Bazzocchi","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib181","first-page":"297","article-title":"A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia","volume":"92","author":"Choi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib182","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10484-007-9037-7","article-title":"Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group","volume":"32","author":"Sanders","year":"2007","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"10.1053\/j.gastro.2026.02.003_bib183","first-page":"1970","article-title":"Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study","volume":"98","author":"Parry","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib184","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2023.05.049","article-title":"Prevalence and associated factors of bloating: results from the Rome Foundation Global Epidemiology Study","volume":"165","author":"Ballou","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib185","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14364","article-title":"Pictograms are more effective than verbal descriptors in Spanish for bloating and distension","volume":"34","author":"Rabago","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib186","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2023.04.039","article-title":"AGA clinical practice update on evaluation and management of belching, abdominal bloating, and distention: expert review","volume":"165","author":"Moshiree","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib187","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ajg.2010.408","article-title":"Abdomino-phrenic dyssynergia in patients with abdominal bloating and distension","volume":"106","author":"Villoria","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib188","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14229","article-title":"Symptom severity and clinical characteristics of patients with bloating","volume":"34","author":"Gardiner","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib189","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2020.03.056","article-title":"Management of chronic abdominal distension and bloating","volume":"19","author":"Lacy","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.gastro.2024.03.005","article-title":"Thoracoabdominal wall motion-guided biofeedback treatment of abdominal distention: a randomized placebo-controlled trial","volume":"167","author":"Barba","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib191","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial","volume":"145","author":"Pimentel","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2026.02.003_bib192","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.14309\/ajg.0000000000002281","article-title":"What is unspecified functional bowel disorder? A commonly seen, rarely recognized, and poorly understood diagnosis","volume":"118","author":"Ballou","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.02.003_bib193","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14268","article-title":"Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders","volume":"34","author":"Goodoory","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.02.003_bib194","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.14309\/ajg.0000000000002376","article-title":"Prevalence and burden of illness of Rome IV chronic idiopathic constipation, opioid-induced constipation, and opioid-exacerbated constipation in the United States","volume":"118","author":"Liang","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2026.02.003_bib195","first-page":"S1","article-title":"Incidence, pathophysiology, and implications of opioid-induced constipation and suggestions for patient-provider interactions","volume":"55","author":"Cash","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.02.003_bib196","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.02.003_bib197","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.cgh.2018.01.021","article-title":"Efficacy of treatments for opioid-induced constipation: systematic review and meta-analysis","volume":"16","author":"Nee","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.02.003_bib198","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpain.2010.11.008","article-title":"Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study","volume":"12","author":"Michna","year":"2011","journal-title":"J Pain"},{"key":"10.1053\/j.gastro.2026.02.003_bib199","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with noncancer pain","volume":"370","author":"Chey","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:20:31Z","timestamp":1786350031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":199,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0016508526001320"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.02.003","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bowel Disorders","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}